Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

Open access
Wang, Han-Min, Zhang, Chan-Yuan, Peng, Kai-Cheng, Chen, Ze-Xin, Su, Jun-Wei, Li, Yu-Fa, Li, Wen-Feng, Gao, Qing-Yun, Zhang, Shi-Ling, Chen, Yu-Qing, Zhou, Qing, Xu, Cong, Xu, Chong-Rui, Wang, Zhen, Su, Jian, Yan, Hong-Hong, Zhang, Xu-Chao, Chen, Hua-Jun, Wu, Yi-Long, Yang, Jin-Ji · 2023 · Cell Reports Medicine

Abstract

Predicting the clinical response to chemotherapeutic or targeted treatment in patients with locally advanced or metastatic lung cancer requires an accurate and affordable tool. Tumor organoids are a potential approach in precision medicine for predicting the clinical response to treatment. However, their clinical application in lung cancer has rarely been reported because of the difficulty in generating pure tumor organoids. In this study, we have generated 214 cancer organoids from 107 patients, of which 212 are lung cancer organoids (LCOs), primarily derived from malignant serous effusions. LCO-based drug sensitivity tests (LCO-DSTs) for chemotherapy and targeted therapy have been performed in a real-world study to predict the clinical response to the respective treatment. LCO-DSTs accurately predict the clinical response to treatment in this cohort of patients with advanced lung cancer. In conclusion, LCO-DST is a promising precision medicine tool in treating of advanced lung cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xcrm.2022.100911

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 192

Metadata

Authors
Wang, H.-M., Zhang, C.-Y., Peng, K.-C., Chen, Z.-X., Su, J.-W., Li, Y.-F., Li, W.-F., Gao, Q.-Y., Zhang, S.-L., Chen, Y.-Q., Zhou, Q., Xu, C., Xu, C.-R., Wang, Z., Su, J., Yan, H.-H., Zhang, X.-C., Chen, H.-J., Wu, Y.-L., & Yang, J.-J.
Venue
Cell Reports Medicine
Publisher
Elsevier BV
Published
2023-02
Volume
4
Issue
2
Pages
100911
ISSN
2666-3791 (ISSN-L)
OpenAlex
W4317240973
Cited by
192
References
17
FWCI
30.50
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study. https://app.cochat.ai/papers/10.1016/j.xcrm.2022.100911
The paper
Wang, H.-M., Zhang, C.-Y., Peng, K.-C., Chen, Z.-X., Su, J.-W., Li, Y.-F., Li, W.-F., Gao, Q.-Y., Zhang, S.-L., Chen, Y.-Q., Zhou, Q., Xu, C., Xu, C.-R., Wang, Z., Su, J., Yan, H.-H., Zhang, X.-C., Chen, H.-J., Wu, Y.-L., & Yang, J.-J. (2023). Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2022.100911

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.